From Xtant Medical’s 510(k) extension to Varian Medical’s distribution deal, here are seven medtech stories we missed this week but thought were still worth a mention. 1. FDA extends Xtant Medical’s 510(k) for Calix C spinal implant Xtant Medical announced in an Aug. 9 press release that the FDA has cleared its product line extensions […]
Technology
Mayo Clinic, nference launch startup to leverage AI for drug development
Mayo Clinic and nference today launched a startup, Qrativ, focused on drug development driven by artificial intelligence. The company, backed by a $8.3 million Series A round, plans to combine nference’s AI platform and Mayo Clinic’s clinical data. Qrativ hopes to use AI to discover potential new therapeutic indications for drugs earlier in development, in […]
Bigfoot Biomedical’s CEO talks disruption in diabetes management tech
Bigfoot Biomedical is a highly competitive player in medtech’s race to develop an artificial pancreas. The 50-person company has made rapid progress towards developing a smart, automated insulin delivery system since its beginnings in 2014. Just yesterday Bigfoot announced that it is partnering with Abbott, bringing together Abbott’s FreeStyle Libre glucose monitoring tech and Bigfoot’s insulin […]
Equashield seeks to automate hazardous drug handling: a Drug Delivery Business News podcast
Equashield’s Jason Dutcher chats with Drug Delivery Business News editor Sarah Faulkner about the company’s closed system transfer device and its latest move to automate hazardous drug compounding. Healthcare workers are often tasked with handling hazardous drugs, which give off harmful vapors. Exposure to these drugs has been linked to severe health risks, including infertility, […]
SICPA aims to arm companies against counterfeit drugs, devices
Counterfeit drugs and medical devices are a pervasive problem for the pharmaceutical industry and for consumers. It’s an issue that affects countries around the world, according to SICPA, a firm that has developed secured identification and traceability solutions for companies to assess and manage risks to their products. “In places like Sub-Saharan Africa, 30-40% of […]
Roche buys mySugr diabetes app
Swiss drugmaker Roche (PINK:RHHBY) said today that it bought diabetes management platform mySugr for an undisclosed price. The 2 companies have worked together since 2014. mySugr’s digital tech enables users to track things like their blood sugar, diabetes medications and physical activity. Roche’s diabetes diagnostic biz has recently faced pricing pressure, bringing about rumors that it […]
Insulin management software wins FDA nod
Insulin Algorithms said today that its decision-support software, designed to help clinicians manage insulin for patients with diabetes, won FDA clearance. The company’s software allows clinicians to analyze a patient’s blood sugar measurements regularly and develop an optimized plan for the patient’s insulin regimen. The software was developed with algorithms that are clinically proven to lower […]
11 companies with interesting technology at MD&M East
Thousands of engineers and executives are expected to descend on the Javits Center in New York next week for MD&M East, the largest medical device manufacturing event on the East Coast. Fun attractions include Apple co-founder Steve “Woz” Wozniak delivering a keynote speech, the 19th annual Medical Design Excellence Awards, robot battles and a 3D printed […]
10 companies with interesting technology at BIOMEDevice Boston
BIOMEDevice Boston is an opportunity for over 4,000 engineers and executives and 400 suppliers in New England’s design and manufacturing industry to connect. It is an industry showcase created by UBM in partnership with Massachusetts Medical Device Industry Council (MassMEDIC). The event – running May 3–4 at the Boston Convention and Exhibition Center – features […]
How artificial life spawned a billion-dollar industry
(Reuters) – Scientists are getting closer to building life from scratch and technology pioneers are taking notice, with record sums moving into a field that could deliver novel drugs, materials, chemicals and even perfumes. Despite ethical and safety concerns, investors are attracted by synthetic biology’s wide market potential and the plummeting cost of DNA synthesis, […]
